Cell cycle disorder was the major event occurring in MCL, characterized by overexpression of cyclin D1, stimulation of cyclin-dependent kinase (CDK) 4 or 6 and depletion of CDK inhibitor p16 INK4. Here, CCND1 is linked to mantle cell lymphoma.